<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is an aggressive <z:hpo ids='HP_0002664'>neoplasm</z:hpo> with poor prognosis as a result of early lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To measure lymphatic vessel density (LVD) in the <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> from Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and determine whether LVD can predict the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, to correlate LVD with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and assess whether LVD could be used as a prognostic indicator for outcome or survival </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: LVD and microvascular density (MVD) were assessed after immunohistochemical staining of vessels in Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues and were correlated with clinicopathological features </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: LVD was significantly reduced in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, being half that seen in <z:mpath ids='MPATH_458'>normal</z:mpath> stomach/oesophagus or <z:mpath ids='MPATH_160'>metaplasia</z:mpath>/<z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>LVD did not correlate with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> grade, stage, or clinical outcome; however, patients who had either lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> or invasion of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells into peritumorous lymphatic vessels had a significantly worse overall survival </plain></SENT>
<SENT sid="6" pm="."><plain>MVD was also assessed as a prognostic marker; its increase appeared to be linked more with the development of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> than <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The reduction in lymphatic vessel numbers was not useful for determining disease outcome in the patient group studied </plain></SENT>
<SENT sid="8" pm="."><plain>It is the entry of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells into pre-existing peritumorous lymphatic vessels that confers a significantly worse overall survival </plain></SENT>
</text></document>